TGen Study Finds Genes Associated With Improved Survival For Pancreatic Cancer Patients
August 20, 2015 Use of non-invasive liquid biopsies could predict in which patients the cancer could recur following surgery A study by the Translational Genomics Research Institute (TGen) and other
Massachusetts General Hospital: How Obesity Contributes To and Blocks Treatment of Pancreatic Cancer
July 6, 2016 Blocking signaling pathways that promote fibrosis in tumor microenvironment may be effective in obese patients Massachusetts General Hospital (MGH) investigators have discovered the mechanism by which obesityHighly Promising Nanomedicine Could Improve Treatment For Pancreatic Cancer
August 8, 2016 Source: University of New South Wales Australia Australian cancer researchers have developed a highly promising technology to deliver gene-silencing drugs to treat pancreatic cancer – the most
Study: True Risk for Pancreatic Cancer In Patients With Pancreatic Cysts
Source: American Society for Gastrointestinal Endoscopy July 11, 2016 The overall risk of pancreatic cancer was estimated to be 19.64 times greater in the group with pancreatic cysts. A look
Clinical Trial: New Immune-Stimulating Drug Can Shrink Pancreatic Tumors
April 2016 University of Rochester Medical Center Wilmont Cancer Institute The results of an early (phase 1b) clinical trial for pancreatic cancer show that an experimental therapy can control tumorsSaint Louis University Finds Link Between Acute Pancreatitis and Pancreatic Cancer
February 26.2014 St. Louis University Saint Louis University researchers have found a link between acute pancreatitis (inflammation of the pancreas) and pancreatic cancer, a finding which may eventually lead to
A 10-Year Study Shows Specific Mouth Bacteria May Significantly Increase The Risk of Pancreatic Cancer
Tony Subia April 20, 2016 Compiled from a New York University School of Medicine Press Release A 10-year study finds that the presence of certain bacteria found in the mouth
TGen Launches Two New Clinical Trials To Shrink Pancreatic Cancer Tumors For Advanced Patients
April 13, 2016 The Translational Genomics Research Institute (TGen) and HonorHealth Research Institute have launched 2 new ground-breaking studies that intend to shrink pancreatic cancer tumors in advanced pancreatic cancer
PANCREATIC CANCER COLOR IS PURPLE. SHOULD PURPLE BECOME THE NEW PINK?
Tony Subia February 2016 All cancer is brutal. Some more so than others. Breast cancer has led the way increasing its 5-year survival rate to an astounding 89.4%. Pancreatic cancer
Study Advances Potential Test To Sort Precancerous Pancreatic Cysts From More Harmless Benign Cysts
Release Date: November 17, 2015 By Johns Hopkins Medicne In a “look-back” analysis of data stored on 130 patients with pancreatic cysts, scientists at Johns Hopkins have used gene-based tests
TGen and Dr. Von Hoff Will Lead International Stand Up To Cancer Dream Team To Tackle Pancreatic Cancer
Dr. Daniel D. Von Hoff – TGen Physician-in-Chief and Distinguished Professor, Chief Scientific Officer at HonorHealth Research Institute, and Professor of Medicine at Mayo Clinic – will lead the Dream